A series of group 4 metal tetracarbamates M(O(2)CNR(2))(4) (M = Ti, R = Et, 1a; M = Zr, R = Et, 1b; (i)Pr, 1c; M = Hf, R = Et, 1d; R = (i)Pr, 1e) were studied as catalytic precursors in the solution polymerization of rac-lactide. The titanium complex but not the zirconium and hafnium ones increase the activity by addition of (i)PrOH. The structure of the carbamato ligand markedly influences the molar mass of polymer; the complexes with isopropyl carbamato ligands produced PLA with molar masses up to 94,000 g mol(-1). The main mechanistic aspects of the initial stages of the polymerization reactions were outlined by spectroscopic and computational analyses. In the case of zirconium and hafnium complexes, an interaction between a carbamato ligand and the CH unit of one lactide molecule is established at room temperature. This interaction is followed by the high temperature proton transfer from the lactide to the carbamato O-atom, affording a catalytic active alkoxy complex with release of CO(2) and NHR(2). The polymerization mediated by Ti(O(2)CNEt(2))(4) involves the release of a radical fragment [O(2)CNEt(2)]˙, with consequent generation of a Ti(III) center. The propagating chain is an alcoholate ligand coordinated to a Ti(IV) centre and containing a radical mainly localized at the tail of the chain (DFT, EPR).
Amorphous solid dispersions (SDs) open up exciting opportunities in formulating poorly watersoluble active pharmaceutical ingredients (APIs). In the present study, novel catalytic pretreated softwood cellulose (CPSC) and polyvinylpyrrolidone (PVP) were investigated as carrier polymers for preparing and stabilizing cryogenic co-ground SDs of poorly water-soluble piroxicam (PRX). CPSC was isolated from pine wood (Pinus sylvestris). Raman and Fourier transform infrared (FTIR) spectroscopy, X-ray powder diffraction (XRPD) and differential scanning calorimetry (DSC) were used for characterizing the solid-state changes and drug-polymer interactions. Highresolution scanning electron microscope (SEM) was used to analyze the particle size and surface morphology of starting materials and final cryogenic co-ground SDs. In addition, the molecular aspects of drug-polymer interactions and stabilization mechanisms are presented. The results showed that the carrier polymer influenced both the degree of amorphization of PRX and stabilization against crystallization. The cryogenic co-ground SDs prepared from PVP showed an enhanced dissolution rate of PRX, while the corresponding SDs prepared from CPSC exhibited a clear sustained release behavior. In conclusion, cryogenic co-grinding provides a versatile method for preparing amorphous SDs of poorly water-soluble APIs. The solid-state stability and dissolution behavior of such co-ground SDs are to a great extent dependent on the carrier polymer used.
Homoleptic bismuth alkoxide complexes, Bi(OR) 3 [R = i Pr ( 1 ), t Bu ( 2 ), and CMe 2 i Pr ( 3 )], are used as catalysts in the ring-opening polymerization (ROP) of lactides. In contrast to 1 , two bulkier bismuth alkoxides, 2 and 3, show high activity in the ROP of lactides in toluene at 75 ° C. Notably, Bi III alkoxides 2 and 3 are more active in lactide ROP than Sn II octoate activated with n -butanol under identical reaction conditions. Bismuth alkoxides 2 and 3 exhibit a living behavior in the ROP of lactides that is demonstrated both in homopolymerization and in a polymerization resumption experiment. Polymerization of rac -lactide using 2 and 3 yields polylactide with a slight heterotactic bias. In addition, 2 is an effi cient initiator for the ROP of ε -caprolactone in bulk at 120 ° C. Variation of the monomer-to-catalyst ratio yielded poly( ε -caprolactone) with M n s up to 120 000 g mol − 1 in corrected gel-permeation chromatography (GPC) data.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.